SUMMIT MEDICAL SYSTEMS INC /MN/
NT 10-K, 1997-04-01
PREPACKAGED SOFTWARE
Previous: ONTRAK SYSTEMS INC, 8-K, 1997-04-01
Next: BRIAN H CORP, POS AM, 1997-04-01



<PAGE>
 
                                                              ------------------
                                 UNITED STATES                   OMB APPROVAL
                      SECURITIES AND EXCHANGE COMMISSION      ------------------
                            Washington, D.C. 20549               OMB Number:
                                                                  3235-0058
                                  FORM 12b-25                  Expires:
                                                                  June 30, 1994
                          NOTIFICATION OF LATE FILING          Estimated
                                                               average burden
                                                               hours per
(Check One):  [X] Form 10-K  [_] Form 20-F  [_] Form 11-K      response....2.50
                      [_] Form 10-Q  [_] Form N-SAR           ------------------
                                                              ------------------
    For Period Ended:    December 31, 1996                      SEC FILE NUMBER
                     --------------------------------------       0-26390
    [_] Transition Report on Form 10-K                        ------------------
    [_] Transition Report on Form 20-F                        ------------------
    [_] Transition Report on Form 11-K                           CUSIP NUMBER
    [_] Transition Report on Form 10-Q                           86613P-10-2
    [_] Transition Report on Form N-SAR                       ------------------
    For the Transition Period Ended:                           
                                    --------------------------------------------
================================================================================
 Read Instruction (on back page) Before Preparing Form.  Please Print or Type.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS 
VERIFIED ANY INFORMATION CONTAINED HEREIN.
================================================================================
If the notification relates to a portion of the filing checked above, identify 
the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------
PART I--REGISTRANT INFORMATION
- --------------------------------------------------------------------------------
Full Name of Registrant
    Summit Medical Systems, Inc.
- --------------------------------------------------------------------------------
Former Name if Applicable
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
    10900 Red Circle Drive
- --------------------------------------------------------------------------------
City, State and Zip Code
    Minnetonka, Minnesota  55343
- --------------------------------------------------------------------------------
PART II--RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense 
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed.  (Check box if appropriate)
       (a)  The reasons described in reasonable detail in Part III of this form
            could not be eliminated without unreasonable effort or expense;
       (b)  The subject annual report, semi-annual report, transition report on
            Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
  [X]       filed on or before the fifteenth calendar day following the
            prescribed due date; or the subject quarterly report or transition
            report on Form 10-Q, or portion thereof will be filed on or before
            the fifth calendar day following the prescribed due date; and
       (c)  The accountant's statement or other exhibit required by Rule 
            12b-25(c) has been attached if applicable.
PART III--NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q, N-
SAR, or the transition report or portion thereof, could not be filed within the
prescribed time period. 

The Registrant is unable to file its 1996 Annual Report on Form 10-K because the
Registrant is finalizing a restatement of the Registrant's financial statements
for the years 1995 and 1994 and the nine months ended September 30, 1996
(collectively, the "Financial Statements") and the Registrant's independent
auditors are completing their audit with respect to 1996. The restatement is
based on an investigation by the Registrant's management, auditors and outside
counsel of the Registrant's accounting practices after concerns were brought to
the attention of senior management and the Registrant's Board of Directors by a
new chief financial officer on February 27, 1997. This investigation has been 
on-going under the direction of the Registrant's Audit Committee of the Board of
Directors and the Registrant's independent auditors have expanded the scope of 
their audit and have performed additional audit procedures.  Due to this 
investigation and additional audit review, as of March 31, 1997, the Registrant
was not able to complete the restatement of the Financial Statements, the 
independent auditors were unable to complete their audit review and the
Registrant was unable to timely file its 1996 Form 10-K without unreasonable
effort and expense. Pursuant to the requirements of Rule 12b-25 of the
Securities Exchange Act of 1934 (as amended), the Registrant expects to file its
1996 Form 10-K no later than April 4, 1997.

                                                               SEC 1344 (11-91)

PART IV--OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this 
     notification

        Richard Willemin                     (612)         939-2200 
     ------------------------------------  ----------- -------------------------
                  (Name)                   (Area Code)     (Telephone Number)

(2)  Have all other periodic reports required under Section 13
     or 15(d) of the Securities Exchange Act of 1934 or 
     Section 30 of the Investment Company Act of 1940 during the
     preceding 12 months (or for such shorter) period that the
     registrant was required to file such reports) been filed?
     If the answer is no, identify report(s).                    [X] Yes  [_] No

                                        
     ---------------------------------------------------------------------------

(3)  Is it anticipated that any significant change in results of
     operations from the corresponding period for the last
     fiscal year will be reflected by the earnings statements to
     be included in the subject report or portion thereof?       [X] Yes  [_] No

     If so, attach an explanation of the anticipated change, both narratively 
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

     As discussed in the narrative under Part III of this Form 12b-25, the
     Registrant is finalizing a restatement of the Registrant's financial
     statements for the years 1995 and 1994 and the nine months ended September
     30, 1996. Until such restatement is completed, the Registrant believes it
     is unable to provide a reasonable estimate of any significant changes in
     results of operations.
- --------------------------------------------------------------------------------

                          Summit Medical Systems, Inc.
          ----------------------------------------------------------
                 (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned 
hereunto duly authorized.


Date  April 1, 1997                     By  /s/ Richard Willemin
    ----------------------------------    --------------------------------------
                                            Interim Vice President, Finance
                                             and Chief Financial Officer

INSTRUCTION:  The form may be signed by an executive officer of the registrant 
or by any other duly authorized representative.  The name and title of the 
person signing the form shall be typed or printed beneath the signature.  If the
statement is signed on behalf of the registrant by an authorized representative 
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

- --------------------------------- ATTENTION ------------------------------------
                INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT                  
         CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).          
- --------------------------------------------------------------------------------

                             GENERAL INSTRUCTIONS

1.   This form is required by Rule 12b-25 (17 CFR 240,12b-25) of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed original and four conformed copies of this form and amendments 
     thereto must be completed and filed with the Securities and Exchange
     Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the 
     General Rules and Regulations under the Act.  The information contained in
     or filed with the form will be made a matter of public record in the
     Commission files.

3.   A manually signed copy of the form and amendments thereto shall be filed 
     with each national securities exchange on which any class of securities of
     the registrant is registered.

4.   Amendments to the notifications must also be filed on form 12b-25 but need
     not restate information that has been correctly furnished.  The form shall
     be clearly identified as an amended notification.

5.   Electronic Filers.  This form shall not be used by electronic filers unable
     to timely file a report solely due to electronic difficulties.  Filers
     unable to submit a report within the time period prescribed due to 
     difficulties in electronic filing should comply with either Rule 201 or
     Rule 202 of Regulation S-T or apply for an adjustment in filing date 
     pursuant to Rule 13(b) of Regulation S-T.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission